Some studies have (20, 26) found that there was no significant difference in survival between low and high VEGF expression groups before antitumor therapy, and they proposed that serum VEGF was not a prognostic marker for predicting ESCC related death. The gene discussed is VEGFA; the disease is esophageal squamous cell carcinoma.